Found: 68
Select item for more details and to access through your institution.
Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Risk factors and prognosis of orotracheal intubation in aquaporin-4-IgG neuromyelitis optica spectrum disorder attacks.
- Published in:
- Annals of Intensive Care, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13613-023-01213-x
- By:
- Publication type:
- Article
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 899, doi. 10.1177/13524585231223880
- By:
- Publication type:
- Article
Clinical correlates of respiratory disorders in patients with severe multiple sclerosis: A cross-sectional cohort.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 726, doi. 10.1177/13524585241238840
- By:
- Publication type:
- Article
Longitudinally extensive posterolateral myelitis revealing invasive CNS aspergillosis in an immunocompetent patient.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 6, p. 755, doi. 10.1177/13524585231221680
- By:
- Publication type:
- Article
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 381, doi. 10.1177/13524585231218149
- By:
- Publication type:
- Article
Control of disease activity with large extended-interval dosing of rituximab/ocrelizumab in highly active pediatric multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 261, doi. 10.1177/13524585231223069
- By:
- Publication type:
- Article
The Response Study: A French registry on pregnancy in women with MS and related disorders and their children up to 6 years—Protocol, recruitment status, and baseline characteristics.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 2, p. 216, doi. 10.1177/13524585231223390
- By:
- Publication type:
- Article
Recurrence of severe symptomatic late-onset neutropenia on ocrelizumab.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 1, p. 131, doi. 10.1177/13524585231206218
- By:
- Publication type:
- Article
Pregnancy and post-partum in patients with myelin-oligodendrocyte glycoprotein antibody-associated disease.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 2, p. 270, doi. 10.1177/13524585221134214
- By:
- Publication type:
- Article
Pregnancy and multiple sclerosis: 2022 recommendations from the French multiple sclerosis society.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 1, p. 11, doi. 10.1177/13524585221129472
- By:
- Publication type:
- Article
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1881, doi. 10.1177/13524585221096975
- By:
- Publication type:
- Article
Post-vaccine COVID-19 in patients with multiple sclerosis or neuromyelitis optica.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 7, p. 1155, doi. 10.1177/13524585211049737
- By:
- Publication type:
- Article
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2280, doi. 10.1177/13524585211006372
- By:
- Publication type:
- Article
Human papillomavirus lesions in 16 MS patients treated with fingolimod: Outcomes and vaccination.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 11, p. 1794, doi. 10.1177/1352458521991433
- By:
- Publication type:
- Article
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 936, doi. 10.1177/1352458519849511
- By:
- Publication type:
- Article
False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Efficacy of rituximab in refractory RRMS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 828, doi. 10.1177/1352458518772748
- By:
- Publication type:
- Article
Dysregulation of energy metabolism in multiple sclerosis measured in vivo with diffusion-weighted spectroscopy.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 3, p. 313, doi. 10.1177/1352458517698249
- By:
- Publication type:
- Article
Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center.
- Published in:
- Frontiers in Neurology, 2017, v. 8, p. 1, doi. 10.3389/fneur.2017.00183
- By:
- Publication type:
- Article
Frequent detection of IFN-gamma-producing memory effector and effector T cells in patients with progressive multifocal leukoencephalopathy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1416074
- By:
- Publication type:
- Article
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Adaptive human immunity drives remyelination in a mouse model of demyelination.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
- Published in:
- Annals of Neurology, 2021, v. 89, n. 1, p. 30, doi. 10.1002/ana.25909
- By:
- Publication type:
- Article
A meta‐analysis comparing first‐line immunosuppressants in neuromyelitis optica.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 10, p. 2025, doi. 10.1002/acn3.51451
- By:
- Publication type:
- Article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data.
- Published in:
- BMC Medical Research Methodology, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12874-021-01285-y
- By:
- Publication type:
- Article
Sclérose en plaques chez le sujet âgé.
- Published in:
- Gériatrie et Psychologie Neuropsychiatrie du Vieillissement, 2017, v. 15, n. 4, p. 402, doi. 10.1684/pnv.2017.0685
- By:
- Publication type:
- Article
Nouveautés thérapeutiques et stratégies émergentes dans la sclérose en plaques.
- Published in:
- Médecine Sciences, 2013, v. 29, n. 12, p. 1105, doi. 10.1051/medsci/20132912013
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
ndividual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 3, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 2, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of disability worsening in Multiple Sclerosis.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 1, p. 1, doi. 10.2967/jnumed.119.231340
- By:
- Publication type:
- Article
Humoral response after accelerated schedule of HBV vaccination in MS patients before anti-CD20 therapy.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2871, doi. 10.1007/s00415-023-12175-2
- By:
- Publication type:
- Article
Anti-MOG associated disease with intracranial hypertension after COVID-19 vaccination.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5647, doi. 10.1007/s00415-022-11130-x
- By:
- Publication type:
- Article
COVID-19 infection in NMO/SD patients: a French survey.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 4, p. 816, doi. 10.1007/s00415-019-09215-1
- By:
- Publication type:
- Article
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
- Published in:
- Journal of Neurology, 2019, v. 266, n. 4, p. 806, doi. 10.1007/s00415-018-9160-9
- By:
- Publication type:
- Article
Extensive and severe CNS demyelination associated with golimumab therapy.
- Published in:
- 2016
- By:
- Publication type:
- Letter
CNS involvement at diagnosis in mantle cell lymphoma with atypical MRI features.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Sex effects across the lifespan in women with multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420936166
- By:
- Publication type:
- Article